182Indexed trials
Market Rank #11 · Evidence Tier A
Japan
Neuroscience Intelligence
Japan neuroscience intelligence: 182 indexed trials, 276 institutions, research score 43.64.
51Recruiting
276Research institutions
43.6Research score
Evidence profile
73Sponsors
23Disease areas
0Institution works
0Institution citations
Evidence signals
Research score 43.6 · Data confidence 100.00 · Evidence 43.6
Data confidence measures presence of evidence layers, not a probability of success. Scores are comparative decision-support signals, not guaranteed market size or commercial outcomes.
Leading disease areas
parkinsons42trials
alzheimers38trials
epilepsy24trials
neuromuscular12trials
depression10trials
schizophrenia7trials
stroke6trials
other_neurology5trials
adhd4trials
migraine_headache4trials
Leading indexed sponsors
Merck Sharp & Dohme LLC22trials
Eli Lilly and Company15trials
Hoffmann-La Roche10trials
Eisai Co., Ltd.9trials
Takeda7trials
Biogen6trials
GlaxoSmithKline6trials
AbbVie5trials
Boehringer Ingelheim5trials
Eisai Inc.4trials